Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA small amount of liquid appearing at the injection site after using your Mounjaro KwikPen is more common than most people expect. It does not automatically mean your dose is lost, but understanding why leakage happens — and how to minimise it — matters for getting the most from your treatment. Mounjaro is a prescription-only medicine; any concerns about technique should be discussed with your prescribing team. This page covers the practical reasons leakage occurs and the steps that tend to help.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It helps to set realistic expectations first. The liquid you see on the skin surface after removing the KwikPen is usually only a tiny fraction of the injected volume, often no more than a droplet. Because the dose is delivered subcutaneously (into the fatty tissue beneath the skin), most of the medicine has already dispersed before the needle withdraws. A visible bead on the surface is rarely the same as losing a meaningful portion of your dose.
That said, repeated or significant leakage is worth paying attention to. If you consistently see more than a very small amount, or you notice a wet patch in your clothing straight after injecting, it is reasonable to mention this at your next clinical review. Your prescriber can assess whether your technique needs adjusting and, importantly, whether your dosing is working as expected. The Mounjaro injection technique page covers the full process step by step if you want a baseline to check against.
One thing to be clear about: do not re-inject the dose on the assumption it was lost. Unless your clinical team specifically advises this, injecting a second time risks double-dosing, which increases side-effect risk. When in doubt, leave it and contact your prescriber.
Several factors contribute, and most are fixable. The most frequent cause is withdrawing the pen before the injection is fully delivered. The KwikPen has a mechanism that requires you to hold it firmly against the skin for a set period after pressing the button, the Patient Information Leaflet (PIL) specifies exactly how long. Lifting the pen a second or two too early leaves a portion of the medicine with nowhere to go except back along the needle track.
A second common cause is repeated use of the same injection site. The NHS guidance on weight-management injections recommends rotating between the abdomen, thigh and upper arm, and moving to a different spot within each area each week. Scar tissue and hardened skin from repeated injections in the same spot absorb the medicine less efficiently and are more likely to produce surface leakage.
Other contributing factors include injecting into skin that is pinched too tightly (or not enough), using a blunt or bent needle (which is why changing the needle before each injection matters) and injecting at too shallow an angle. Some people also find that very lean injection sites produce more surface leakage simply because there is less subcutaneous tissue to receive the full volume. If this applies to you, the abdomen tends to offer the most consistent depth.
Fresh needles make a real difference here. The 100-pack of compatible needles is a practical way to ensure you are never reusing one.
Not directly, but storage conditions can affect the pen's mechanism and the viscosity of the solution, which in turn affects delivery. Mounjaro should be kept refrigerated between 2°C and 8°C. Taking the pen straight from the fridge and injecting immediately without letting it reach room temperature can make the solution slightly harder to express, which some people try to compensate for by pressing harder or moving too quickly, both of which can cause leakage.
Letting the pen sit at room temperature for a short while before injecting is commonly recommended for comfort and smooth delivery. If you are unsure how long you can safely leave it out before use, our dedicated page on how long you can leave Mounjaro out of the fridge covers the permitted window in detail. The guide to Mounjaro fridge storage explains the core storage rules, and our dedicated page on what happens if you leave Mounjaro out of the fridge covers the temperature windows in detail. If you want a broader overview of how to look after your pen correctly, the Mounjaro storage guide brings together the key handling rules in one place.
It is also worth checking the pen for any visible damage before each injection. A cracked cartridge or compromised seal can cause inconsistent delivery. If you spot anything unusual about the pen's appearance or the solution inside, do not use it, contact your prescriber or pharmacy.
Most occasional, minor leakage resolves once technique is refined. Contact your prescriber if: leakage is happening consistently on most injections; you notice a noticeably larger volume than a single droplet; the injection site is unusually painful, swollen, or showing signs of infection; or you feel uncertain whether your dose is being delivered effectively at all.
A practical way to monitor this is to keep brief notes, which site you used, whether you noticed leakage, and how you feel in the day or two following each injection. It is the kind of information that helps a prescriber identify a pattern quickly. If your weight loss has plateaued unexpectedly and you have been noticing leakage, the two could be connected, and your clinical team should know about both together.
If you are considering whether tirzepatide is the right treatment for your situation, or you have questions about the broader treatment picture (including how Mounjaro is priced privately in the UK) the weight-loss treatment overview is a good starting point. Every person at nume has their consultation reviewed personally by a GPhC-registered Independent Prescriber, and aftercare is available seven days a week. You can read more about the clinical team at our prescriber profile.
For reporting any side effects (including injection-site reactions) directly to the regulator, the MHRA's Yellow Card scheme is open to patients and carers. The NHS tirzepatide patient information page also covers injection-site reactions and side effects in plain language. If you have questions outside of these topics, the general FAQs or our contact page are there when you need them.
Ready to speak to a prescriber? Check your eligibility and start your free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.